Page 32 - Cascade_Biocatalysis_Integrating_Stereoselective_and_Environmentally_Friendly_Reactions
P. 32

8  1 Directed Evolution of Ligninolytic Oxidoreductases

                    and enzymatic co-factor regeneration. Recently, the MtL-R2 mutant was converted
                    into an alkalophilic fungal laccase [43]. Accordingly, a high-throughput screening
                    (HTS) assay based on the activity ratio at pH 8.0 to 5.0 was used as the main
                    discriminatory factor. Screening the laccase mutant libraries at alkaline pH while
                    conserving activity at acidic pHs led to a shift in the pH activity profiles that was
                    accompanied by improved catalytic efficiency at both pH values (31-fold at pH 7.0
                    and 12-fold at pH 4.0). The final variant obtained in this evolution experiment (the
                    IG-88 mutant) retained 90% of its activity at pH 4.0–6.0 and 50% at pH 7.0, and
                    some activity was even detected at pH 8.0.
                      After 20 generations, the successful in vitro evolution of MtL can be attributed to
                    the plasticity and robustness of this thermostable protein, highlighting that there
                    may be an additional margin for further engineering.

                    1.4.3
                    Directed Evolution of Ligninolytic High-Redox Potential Laccases (HRPLs)

                    Two HRPLs from the basidiomycete PM1 laccase (PM1L) and Pycnoporus cinnabar-
                    inus laccase (PcL) were subjected to parallel comprehensive directed evolution
                    in order to achieve functional expression in S. cerevisiae while conserving their
                    thermostability [44]. PM1L was tailored during eight cycles of directed evolution
                    combined with semirational/hybrid approaches [45]. The native laccase signal
                    sequence was replaced by the α-factor prepro-leader from S. cerevisiae and it was
                    evolved in conjunction with the mature protein, adjusting both elements for a
                    successful exportation by yeast. After screening over 50 000 clones, this approach
                    led to the generation of a highly active, soluble, and thermostable HRPL. The total
                    improvement in activity achieved was as high as 34 000-fold relative to the parental
                    type, an effect brought about by the synergies established between the evolved
                    prepro-leader and the mature laccase. Several strategies were employed to main-
                    tain the stability of the laccase while enhancing its activity and secretion during
                    evolution: (i) screening for stabilizing mutations [46]; (ii) mutational exchange with
                    beneficial PcL mutations; and (iii) mutational recovery of beneficial mutations with
                    a low likelihood of recombination [44, 47].
                      The final mutant generated in this process (the OB-1 variant with 15 mutations
                    accumulated both in the prepro-leader and in the mature protein) exhibited
                                         −1
                    secretion levels of ∼8mgl , and it was very active and stable over a range of
                                       ◦
                    temperatures (T 50  ∼ 73 C) and pH values, as well as in the presence of organic
                    co-solvents [45]. OB-1 was recently subjected to four further rounds of directed
                    evolution and saturation mutagenesis in order to achieve activity in human blood,
                    a milestone that will allow it to be used in a wide array of exciting biomedical and
                    bioanalytical applications [48]. The inherent inhibition of laccase by the combined
                    action of high NaCl concentrations (∼140 mM) and the alkaline pH (∼7.4) of blood
                    was overcome by using an ad hoc HTS assay in a buffer that simulated blood
                    but lacked coagulating agents and red blood cells. Bearing in mind that HRPLs
                    are not active at neutral pH, the selective pressure was enhanced in successive
                    rounds of evolution, starting at pH 6.5 and finishing at physiological pH. The final
   27   28   29   30   31   32   33   34   35   36   37